214 related articles for article (PubMed ID: 31200090)
1. Anti-repulsive guidance molecule-a antibody treatment and repetitive transcranial magnetic stimulation have synergistic effects on motor recovery after spinal cord injury.
Nakanishi T; Fujita Y; Tanaka T; Yamashita T
Neurosci Lett; 2019 Sep; 709():134329. PubMed ID: 31200090
[TBL] [Abstract][Full Text] [Related]
2. An enhanced therapeutic effect of repetitive transcranial magnetic stimulation combined with antibody treatment in a primate model of spinal cord injury.
Yamanaka H; Takata Y; Nakagawa H; Isosaka-Yamanaka T; Yamashita T; Takada M
PLoS One; 2021; 16(6):e0252023. PubMed ID: 34077429
[TBL] [Abstract][Full Text] [Related]
3. Delayed administration of the human anti-RGMa monoclonal antibody elezanumab promotes functional recovery including spontaneous voiding after spinal cord injury in rats.
Mothe AJ; Coelho M; Huang L; Monnier PP; Cui YF; Mueller BK; Jacobson PB; Tator CH
Neurobiol Dis; 2020 Sep; 143():104995. PubMed ID: 32590037
[TBL] [Abstract][Full Text] [Related]
4. Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primates.
Jacobson PB; Goody R; Lawrence M; Mueller BK; Zhang X; Hooker BA; Pfleeger K; Ziemann A; Locke C; Barraud Q; Droescher M; Bernhard J; Popp A; Boeser P; Huang L; Mollon J; Mordashova Y; Cui YF; Savaryn JP; Grinnell C; Dreher I; Gold M; Courtine G; Mothe A; Tator CH; Guest JD
Neurobiol Dis; 2021 Jul; 155():105385. PubMed ID: 33991647
[TBL] [Abstract][Full Text] [Related]
5. Treatment With the Neutralizing Antibody Against Repulsive Guidance Molecule-a Promotes Recovery From Impaired Manual Dexterity in a Primate Model of Spinal Cord Injury.
Nakagawa H; Ninomiya T; Yamashita T; Takada M
Cereb Cortex; 2019 Feb; 29(2):561-572. PubMed ID: 29315368
[TBL] [Abstract][Full Text] [Related]
6. Delayed administration of elezanumab, a human anti-RGMa neutralizing monoclonal antibody, promotes recovery following cervical spinal cord injury.
Mothe AJ; Jacobson PB; Caprelli M; Ulndreaj A; Rahemipour R; Huang L; Monnier PP; Fehlings MG; Tator CH
Neurobiol Dis; 2022 Oct; 172():105812. PubMed ID: 35810963
[TBL] [Abstract][Full Text] [Related]
7. RGMa inhibition with human monoclonal antibodies promotes regeneration, plasticity and repair, and attenuates neuropathic pain after spinal cord injury.
Mothe AJ; Tassew NG; Shabanzadeh AP; Penheiro R; Vigouroux RJ; Huang L; Grinnell C; Cui YF; Fung E; Monnier PP; Mueller BK; Tator CH
Sci Rep; 2017 Sep; 7(1):10529. PubMed ID: 28874746
[TBL] [Abstract][Full Text] [Related]
8. RGMa inhibition promotes axonal growth and recovery after spinal cord injury.
Hata K; Fujitani M; Yasuda Y; Doya H; Saito T; Yamagishi S; Mueller BK; Yamashita T
J Cell Biol; 2006 Apr; 173(1):47-58. PubMed ID: 16585268
[TBL] [Abstract][Full Text] [Related]
9. Effects of high-frequency transcranial magnetic stimulation on functional performance in individuals with incomplete spinal cord injury: study protocol for a randomized controlled trial.
de Araújo AVL; Barbosa VRN; Galdino GS; Fregni F; Massetti T; Fontes SL; de Oliveira Silva D; da Silva TD; Monteiro CBM; Tonks J; Magalhães FH
Trials; 2017 Nov; 18(1):522. PubMed ID: 29110687
[TBL] [Abstract][Full Text] [Related]
10. Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) and Treadmill Training on Recovery of Motor Function in a Rat Model of Partial Spinal Cord Injury.
Wang P; Yin R; Wang S; Zhou T; Zhang Y; Xiao M; Wang H; Xu G
Med Sci Monit; 2021 Jul; 27():e931601. PubMed ID: 34304239
[TBL] [Abstract][Full Text] [Related]
11. Synapse formation of the cortico-spinal axons is enhanced by RGMa inhibition after spinal cord injury.
Kyoto A; Hata K; Yamashita T
Brain Res; 2007 Dec; 1186():74-86. PubMed ID: 17996222
[TBL] [Abstract][Full Text] [Related]
12. Analgesia-enhancing effects of repetitive transcranial magnetic stimulation on neuropathic pain after spinal cord injury:An fNIRS study.
Sun X; Long H; Zhao C; Duan Q; Zhu H; Chen C; Sun W; Ju F; Sun X; Zhao Y; Xue B; Tian F; Mou X; Yuan H
Restor Neurol Neurosci; 2019; 37(5):497-507. PubMed ID: 31381538
[TBL] [Abstract][Full Text] [Related]
13. Effects of high frequency repetitive transcranial magnetic stimulation on KCC2 expression in rats with spasticity following spinal cord injury.
Gao W; Yu LG; Liu YL; Chen M; Wang YZ; Huang XL
J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):777-781. PubMed ID: 29058295
[TBL] [Abstract][Full Text] [Related]
14. Effects of high-frequency repetitive transcranial magnetic stimulation on motor and gait improvement in incomplete spinal cord injury patients.
Kumru H; Benito J; Murillo N; Valls-Sole J; Valles M; Lopez-Blazquez R; Costa U; Tormos JM; Pascual-Leone A; Vidal J
Neurorehabil Neural Repair; 2013 Jun; 27(5):421-9. PubMed ID: 23322551
[TBL] [Abstract][Full Text] [Related]
15. Elezanumab, a clinical stage human monoclonal antibody that selectively targets repulsive guidance molecule A to promote neuroregeneration and neuroprotection in neuronal injury and demyelination models.
Huang L; Fung E; Bose S; Popp A; Böser P; Memmott J; Kutskova YA; Miller R; Tarcsa E; Klein C; Veldman GM; Mueller BK; Cui YF
Neurobiol Dis; 2021 Nov; 159():105492. PubMed ID: 34478849
[TBL] [Abstract][Full Text] [Related]
16. Effects of repetitive transcranial magnetic stimulation on recovery of function after spinal cord injury.
Tazoe T; Perez MA
Arch Phys Med Rehabil; 2015 Apr; 96(4 Suppl):S145-55. PubMed ID: 25175159
[TBL] [Abstract][Full Text] [Related]
17. Promoting functions of microRNA-29a/199B in neurological recovery in rats with spinal cord injury through inhibition of the RGMA/STAT3 axis.
Yang W; Sun P
J Orthop Surg Res; 2020 Sep; 15(1):427. PubMed ID: 32948213
[TBL] [Abstract][Full Text] [Related]
18. Combination of repetitive transcranial magnetic stimulation and treadmill training reduces hyperreflexia by rebalancing motoneuron excitability in rats after spinal cord contusion.
Wang S; Wang P; Yin R; Xiao M; Zhang Y; Reinhardt JD; Wang H; Xu G
Neurosci Lett; 2022 Apr; 775():136536. PubMed ID: 35183693
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting repulsive guidance molecule-a suppresses secondary progression in mouse models of multiple sclerosis.
Tanabe S; Fujita Y; Ikuma K; Yamashita T
Cell Death Dis; 2018 Oct; 9(11):1061. PubMed ID: 30333477
[TBL] [Abstract][Full Text] [Related]
20. Effect of repetitive transcranial magnetic stimulation over the hand motor cortical area on central pain after spinal cord injury.
Kang BS; Shin HI; Bang MS
Arch Phys Med Rehabil; 2009 Oct; 90(10):1766-71. PubMed ID: 19801069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
